PRF Technologies In FY25 Had ~$4.1M In Cash, Cash Equivalents, Short-Term Deposits And Restricted Cash And Positive Working Capital Of ~$1.9M

LayerBio's OcuRing™-K program and broader ocular platform strengthen PRF's healthcare growth strategy

DeepSolar advances from acquisition to early commercial deployment